Franklin Templeton Investments has appointed Scott Collison as head of alternatives sales, Asia.
Reporting to Mark Browning, managing director, Asia, Collison is responsible for new business development of the group’s alternative products in Asia.
Based in Singapore, he will work closely with existing regional and country institutional and retail distribution teams, to develop and implement country level strategies to support the growth of Franklin Templeton’s alternative products in Asia.
Collison brings with him over 20 years of experience in the financial markets; 18 years of his experience has been in institutional investing and in building alternative asset management businesses. Prior to joining Franklin Templeton in 2013, Collison was the CEO of Talos Strategies, an advisory business for both traditional and alternatives asset managers. Collison founded and managed the Orvent Fund – one of the largest Asian hedge fund start up in 2011 – and was previously portfolio manager at Millennium Partners in Singapore. Collison earlier spent over 12 years at Credit Suisse First Boston as an equities and derivatives trader.
Browning says: “We see growing interest in alternative products from both Asian institutions and high net worth individuals. The continued expansion of Franklin Templeton’s alternatives and solutions platform remains a core strategic initiative for our business and I am delighted that Scott has joined us in this newly-created position. Investor appetite for alternatives investments is warming up across the region and we are well-positioned for alternatives sales growth both in the traditional institutional market as well as within the wealth management channel.”
Collison says: “This is an exciting opportunity. Franklin Templeton is one of the world’s largest asset managers with extensive presence globally. The group has an excellent array of products which offer tremendous opportunity for the alternatives channel.”